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Rax/Rx is a paired-type homeodomain-containing transcription factor that is essential for cell proliferation in the developing eye and brain. The
molecular mechanisms that regulate cell proliferation by rax, however, are largely unknown. Here, we identify the high mobility group B3 gene
(hmgb3) as a downstream target of Xenopus rax (Xrax/XRx1). Overexpression of Xhmgb3 results in an increase in eye and brain sizes due to
promoted cell proliferation, while morpholino-oligo-mediated knock down of Xhmgb3 reduces eye and brain sizes. In addition, ChIP assays
showed that Xhmgb3 is recruited around the promoter region of c-myc to enhance c-myc transcription. We also found that XOptx2 requires rax for
its initial expression. Furthermore, we show that Xhmgb3 and XOptx2 are required for retinal development mainly at different developmental
stages. Our findings reveal a novel aspect of progenitor cell proliferation during embryonic central nervous system (CNS) development.
© 2006 Elsevier Inc. All rights reserved.Keywords: Retina; rax/Rx; Xhmgb3; c-myc; XOptx2; Cell proliferation; XenopusIntroduction
Although mechanisms of neural tissue induction at early
developmental stages are well characterized, less is known
about how cell proliferation is developmentally regulated in the
vertebrate central nervous system (CNS) (De Robertis et al.,
2000; Harland, 2000; Niehrs, 2004; Stern, 2005). The
expansion of mitotic progenitor cells is required for proper
organogenesis. Loss of proliferation in animals leads to
developmental defects and can cause disease. In the vertebrate
CNS, neural progenitor cells undergo proliferation and
subsequent differentiation, leading to a normally sized brain
and eye, and to functional neurons and glial cells (Chitnis, 1999;
Panchision and McKay, 2002; Temple, 2001).
It has been reported that cell-external factors influence
cell proliferation of progenitor cells in the vertebrate CNS.
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doi:10.1016/j.ydbio.2005.12.029the neural plate by the action of morphogens secreted from
adjacent tissues. Positional identity along the anteroposterior
axis is specified by fibroblast growth factor (FGF), Wnt and
retinoid family ligands, whereas the dorsoventral axis is
specified by the antagonistic action of bone morphogenetic
protein (BMP), transforming growth factor (TGF) β ligands
and sonic hedgehog (Shh). FGF, BMP, Wnt, hedgehog and
retinoic acid (RA) act also as mitogens that promote
proliferation of the cells (Panchision and McKay, 2002;
Temple, 2001). On the other hand, cell-internal factors, such
as transcription factors, also play an important role in neural
cell proliferation and differentiation. Loss-of-function assays
showed that Pax6 and Emx2 are required for proliferation as
well as patterning in their respective domains of the cortex,
implying that positional identity genes, induced by morpho-
gens, may directly promote cell proliferation (Bishop et al.,
2000; Estivill-Torrus et al., 2002). In the developing eye,
Optx2/Six6 and Chx10 promote progenitor cell proliferation
by repressing p27 expression (Green et al., 2003; Li et al.,
2002). Six3 regulates retinal progenitor cell proliferation not
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(Bene et al., 2004). It has been also reported that Six3
functions in cell proliferation by repressing p27 in the
anterior neural plate (Gestri et al., 2005). These studies
imply that positional identity genes may regulate progenitor
cell proliferation through common and distinct mechanisms.
On the other hand, widely expressed factors also regulate
cell proliferation of neural progenitors. Sox2 plays a role in
maintenance of neural progenitor cells as well as in
neurogenesis in vertebrates. Sox2 is widely expressed in
the developing nervous system and appears not to be
involved in the specification of regional identity (Graham et
al., 2003). Id4, which is expressed widely in the developing
nervous system in mice, regulates neural progenitor
proliferation by controlling G1–S transition (Yun et al.,
2004). Taken together, both region specific and non-specific
factors contribute to progenitor proliferation in the nervous
system. However, the mechanisms for how these factors
promote cell proliferation are largely unknown, and the
question whether or not mechanisms of proliferation by
region-specific and non-specific factors are related remains
to be answered.
Rax is one of the key molecules essential for cell
proliferation in the anterior neural plate in vertebrates. Rax
is conserved among vertebrates and invertebrates, including
humans, mice, chickens, zebrafish, Medaka, surface fish,
Xenopus and Drosophila. The expression of rax is observed
in the prospective cephalic region in gastrula and in the
optic vesicle after neural tube formation (Casarosa et al.,
1997; Chen and Cepko, 2002; Deschet et al., 1999;
Furukawa et al., 1997; Kimura et al., 2000; Mathers et
al., 1997; Ohuchi et al., 1999; Strickler et al., 2002).
Medaka harboring mutation in Rx3 locus does not develop
an optic vesicle (Loosli et al., 2001) and mutation of rx3 in
zebrafish causes the loss of eyes (Loosli et al., 2003). The
rax null mutant mice show reduced brain size and do not
develop the optic vesicle (Mathers et al., 1997). In humans,
mutations of the RAX gene are associated with anophthalmia
and sclerocornea (Voronina et al., 2004). On the other hand,
rax overexpression induces cell proliferation in the retina
and anterior brain in Xenopus (Andreazzoli et al., 1999,
2003; Casarosa et al., 2003; Mathers et al., 1997). Thus, rax
plays significant roles during embryonic development in
vertebrates, raising the possibility that the investigation of
mechanisms by which rax acts may provide us more
understanding of the mechanisms of cell proliferation during
embryonic development.
In this study, we report the identification of Xenopus
hmgb3 (Xhmgb3) as a downstream factor of rax. HMGB3 is
one of HMGB proteins (HMGB1, 2 and 3), which are non-
histone chromosomal proteins characterized by the HMG
domains, A and B. The HMGB proteins bind to DNA
through the HMG domains and act as architectural
facilitators in the manipulation of nucleoprotein complexes.
The biological roles of the HMGB3 protein during
embryonic development have not been clarified. We
demonstrate that overexpression of Xhmgb3 results in anincrease in eye and brain sizes, and, conversely, knocking
down Xhmgb3 reduces eye and brain sizes in Xenopus. In
addition, we show that Xhmgb3 promotes c-myc transcrip-
tion. We also demonstrate that rax is required for the initial
expression of XOptx2 in Xenopus. Our results indicate that
rax controls cell proliferation in the CNS by at least two
pathways mediated by Xhmgb3 or XOptx2.Materials and methods
Macroarray screen
Synthetic RNAs of rax and smad10 or water were injected into Xenopus
embryos at the 4- or 8-cell stage into four animal blastomeres, followed by
dissection of the animal caps at stages 8/9. Single-strand cDNAs were
generated from total RNA, accompanied by labeling with [α32P] dCTP, then
used as probes for macroarray analysis, which covers 50,000 cDNA clones
from Xenopus embryos at stages 10.5, 15, and 25. The signals were
detected by BAS 5000 (Fuji). The signals that were at least twice as intense
as the control signals were considered positive and subjected to further
analysis. The clone XL154j12 (NIBB XDB, http://xenopus.nibb.ac.jp) which
encodes for Xenopus hmgb3 protein was obtained. This macroarray is
described in a book written by S.F. Gilbert (2003). GenBank accession
number of Xhmgb3b is AY652624.
Xenopus embryos
Embryos were obtained from Xenopus laevis adult frog by hormone-induced
egg laying, in vitro fertilized using standard methods and dejellied (2% cysteine
in water, pH 7.5–8.0). Embryos were staged according to Nieuwkoop and Faber
(1994). Injected embryos were raised at 15°C.
RNA microinjection, RNA synthesis and morpholino oligos
Capped RNAs were synthesized using the mMESSAGE mMACHINE kit
(Ambion). Four animal blastomeres of 4- or 8-cell stage embryos were injected
with capped, synthetic RNA for animal cap dissection. Injections of synthetic
RNA were performed with 60 pg/blastomere of rax, with 1 ng/blastomere of
smad10, with 200 pg/blastomere of rax-EnR, with 225 pg/blastomere of
Xhmgb3, with 450 or 750 pg/blastomere of Xhmgb3 (contains a seven nucleotide
mutation within the MO target sequence for rescue experiments), with 300 pg/
blastomere of 6x myc-tagged Xhmgb3 (6xmyc-Xhmgb3) or 6xmyc tag, and with
75 pg/blastomere of β-galactosidase. pCS2+ rax-EnR was generated according
to a previous report (Andreazzoli et al., 1999). pCS2+ XOptx2 and pCS2+
XOptx2HD-VP16 were provided by Drs. W.A. Harris and M.E. Zuber. pCS2+
smad10 was provided by Dr. J.M. Graff. Xenopus rax/Rx1 cDNA including the
entire coding sequence was obtained by RT-PCR with primers (F), 5′-CCG-
GATCCTCGTGATTGAACACCTCAGGGTCC-3′ and (R), 5′-CCGAATTCG
GCTGCCCTGAGCCGTATTCATATG-3′, sequenced and subcloned into the
pCS2+.
cDNAs encoding for Xhmgb3, 6x-myc tag, 6x-myc-Xhmgb3 and GFP were
subcloned into pCS2+ (Gift from Dr. J.M. Graff). Antisense morpholino-
oligonucleotides (MOs) were purchased from Gene Tools (Philomath, USA).
Sequences of MOs are as follows: Xhmgb3MO, 5′-CTTCTTAGGGTCACGTT-
TAGCCATC-3′, control MO, 5′-CCTCTTACCTCA GTTACAATTTATA-3′.
The sequence of MO against Xenopus rax/Rx1 is as previously described and it
was shown that the effect of rax-EnR and MO against rax/Rx1 was rescued by
rax/Rx1 overexpression (Andreazzoli et al., 2003). MOs were injected in the
amount of 1 pmol (Xhmgb3MO and control MO) or 0.5–1 pmol (raxMO). For
rescue experiments an Xhmgb3 gene that has seven mutations of nucleotides in
the target region of Xhmgb3 MO was used. Xhmgb3b MO has only a one base
pair substitution in the sequence of Xhmgb3a. We performed control
experiments by injecting a control MO (Kinoshita et al., 2003) for all of the
MO injection experiments in this study and confirmed that the control MO did
not affect the expression of all genes we assessed in this study (data not shown).
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Animal caps were dissected from stages 8/9 embryos in 0.5× MMR (Marc's
Modified Ringer's solution) and were incubated until sibling embryos reached
stage 25 and then subjected to further analysis. Total RNA was purified using
TRIzol (Invitrogen).X-gal staining, in situ hybridization, and Northern hybridization
Embryos were grown to the desired stage, devitellinized and fixed in
MEMFA for 30 min followed by a brief wash in PBS and transferred into the X-
gal staining solution until staining was apparent. Whole mount in situ
hybridization was performed essentially as described (Harland, 1991) using
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performed essentially as described (Dorsky et al., 1995) withminormodification.
Cryosections of retina at stages 40/41 were used. The substrate for the
chromogenic reaction was NBT/BCIP. Northern hybridization was performed as
described previously (Furukawa et al., 1997).
Quantification of enlarged eye
Embryos injected with Xhmgb3 + β-gal RNAs or only β-gal RNA were
grown to stages 37/38 and fixed in MEMFA at room temperature for 30 min,
followed by the X-gal staining. The epidermis overlaying the eye was removed.
The eye diameters were measured and used to calculate the percent increase in
eye diameter on the injected side of each embryo.
Immunohistochemistry
Immunostaining of cryosections was performed as described previously
(Nishida et al., 2003). Anti-phospho-histone H3 antibody (Upstate, #06–570),
anti-β-galactosidase antibody (Promega, #Z3781), Cy3-conjugated-anti-rabbit
antibody (Jackson ImmunoResearch Laboratories, #711-165-152) and Cy3-
conjugated-anti-mouse antibody (Jackson ImmunoResearch Laboratories, #711-
165-150) were used at concentrations of 10 μg/ml, 2.3 μg/ml, 7.5 μg/ml, and 7
μg/ml, respectively.
Quantification of anti-phospho-histone H3 antibody positive cells
Cryosections (12 μm) from embryos injected with only β-gal RNA or
Xhmgb3 + β-gal RNAs were subjected to an immunostaining with an anti-
β-gal antibody or an anti-phospho-histone H3 antibody. Among sections
obtained from each embryo, one section was subjected to an anti-β-gal
antibody to confirm the injected side. Positive cells were counted under
fluorescence microscopy. The sum of the number of positive cells on the
sections derived from one embryo was the number of positive cells in the
whole left or right eye. The ratio of the number of positive cells in an
injected eye to the number of positive cells in an un-injected eye was
calculated for each embryo.
In vivo lipofection
DNA was lipofected into the anterior neural fold of stage 18 embryos as
previously described (Holt et al., 1990; Dorsky et al., 1995). GFP DNA was
colipofected to mark the lipofected cells. Embryos were fixed at stage 41,
sectioned on a cryostat at a thickness of 10 μm. GFP-positive cells were counted
and the cell type identified based upon their laminar position and morphology as
previously described (Dorsky et al., 1995, 1997).
Detection of apoptotic cells
Embryos were harvested at stages 31/32 and fixed in MEMFA at room
temperature for 20 min. Cryosections (14 μm) were made from embryos and
subjected to a TUNEL (TdT-mediated dUTP Nick-End Labeling) assay. The
TUNEL assay was performed according to the instruction manual protocolFig. 1. Expression of Xhmgb3 mRNA and regulation of Xhmgb3 by rax. (A–E) Reg
Xhmgb3 (A and B) by rax overexpression. Reduction of Xhmgb3 (C and D) or Xhmg
animal caps injected with water, rax or rax + smad10 RNAs. The cDNA fragment en
panel shows Ethidium Bromide (EtBr) staining of ribosomal RNA (A). In situ hybrid
(stages 18/19) (B) or raxMO (1 pmol) and β-gal RNA (stages 17/18) (C) into one do
to the top (B) or anterior–dorsal view (C). Section in situ hybridization using a probe
embryos injected with raxMO (0.5 pmol) and β-gal RNA. The injected side or areas
red (D and E) and also indicated by green arrows (B, D and E). White brackets at both
and control side (C). (F–U) The expression of Xhmgb3 (F–R) or Xhmgb3a (S–U). An
(G) and stage 15 (H). Lateral views with the anterior to the left (I–N) at stages 18/19 (
and L (M), and stage 39 (N). Yellow arrowheads indicate otic vesicles (M). (O) A c
hybridization using a probe of Xhmgb3. Black dotted lines delineate an optic vesic
forebrain (P) or retina at stages 40–41 (Q and R). (S–U) Expression of Xhmgb3a in
Xhmgb3 or Xhmgb3a around CMZ (Q, R and U).(Promega). Similar results were obtained on several sections in at least two
independent experiments.
Chromatin immunoprecipitation (ChIP)
About fifty animal caps were isolated at stages 8/9 from embryos injected
with the appropriate synthetic RNA, and crosslinked with 1% formaldehyde at
room temperature for 20 min. After rinsing with ice-cold PBS, animal caps were
incubated in 0.125 M glycine for 10 min at room temperature and followed by
the steps described previously (Takebayashi-Suzuki et al., 2003) with minor
modifications. The immunocomplexes were eluted with elution buffer (50 mM
Tris, pH 8.0, 1 mM EDTA and 1% SDS) at 65°C for 20 min. For IP an anti-myc
antibody (Santa Cruz #sc-40) was used. Primer sequences are as follows: for
Primer-set 2, (F) 5′-GTACGAGCCACACACGGAGTTGG-3′ and (R) 5′-
GCTCCGACTGAGCCTTATATAGC-3′; Primer-set 1, (F) 5′-ATGTAATGTA-
TAAGAATTGAGC-3′ and (R) 5′-AAAGGGCACATTCACAAGCAGATATG-
3′; Primer-set-coding, (F) 5′-CCCACTAC AGCCCTTTAGTTCTG-3′ and (R)
5′-TCTGGCGCTCCAGAACGTTG-3′. 28 cycles of amplification were used
for PCR.
Probes for hybridization and primers for RT-PCR
The probes used for hybridization (in situ hybridization and Northern
hybridization) of rax, Xhmgb3, Xhmgb3a and XOptx2 were the entire protein-
coding region of each. Probes for hybridization were obtained by RT-PCR.
Primers for RT-PCR were as followed, Xenopus Pax6, forward (F) 5′-
CAACCTGGCGAGCGATAAGC-3′ and reverse (R) 5′-GTGTATGTGTCATA-
GCTCCG-3′; for Xenopus Six3, (F) 5′-CCAACTTCCCCATGGTGTTCAGGT-
CCCCTC-3′ and (R) 5′-GTCCATAG GAGCCCTGATCTG CCTGGGTCC-3′;
for Xenopus c-myc, (F) 5′-AGCCTTGC TGAAGTCCATCG-3′ and (R) 5′-
TCTGGCGCTCCAGAACGTTG-3′; for Xenopus N-myc, (F) 5′-TTTGAC-
TCCCTGCAACCTTGT-3′ and (R) 5′- CTGCAATTCCTAGCTGTCGTG-3′;
for Xenopus engrailed (En) 2, (F) 5′-GGAAGTGGAGCCACAGCAGG-3′ and
(R) 5′-AGCAGTGA AGGCAGTTCTGG-3′. The cDNA fragments obtained
were subcloned into pGEM-T-easy (Promega) and sequenced.Results
Induction of Xhmgb3 by rax overexpression
To investigate the molecular mechanisms of progenitor cell
proliferation in the developing CNS, we attempted to identify
the downstream mediators of rax using the Xenopus animal cap
assay. Rax can induce transcription factors that are expressed in
the eye field such as Pax6 and XOptx2 in animal caps (Zuber et
al., 2003). However, overexpression of rax could not induce
ectopic eye formation, although rax can induce ectopic retinal
pigmented epithelium (RPE) (Mathers et al., 1997), suggesting
that rax alone could not induce downstream factors efficientlyulation of Xhmgb3 mRNA (A–D) or Xhmgb3a mRNA (E) by rax. Induction of
b3a (E) by raxMO injection. Northern blot analysis of total RNA isolated from
coding for entire protein of Xhmgb3 was used as a labeled probe (A). The lower
ization using a probe of Xhmgb3 for embryos injected with rax and β-gal RNAs
rsal blastomere at 4- or 8-cell stage on the animal side. Anterior view with dorsal
of Xhmgb3 (D) or Xhmgb3a (E) followed by immunostaining against β-gal for
are indicated by β-gal activity in blue (B and C) or by β-gal immunostaining in
sides of midline indicate the anterior expression of Xhmgb3 in raxMO-injected
imal view at stage 10.5 (F). Dorsal views with anterior to the bottom at stage 12.5
I), stage 25 (J), stage 28 (K), stages 33/34 (L), higher magnifications of panels K
ryosection of Xenopus optic vesicle at stage 25 following whole mount in situ
le. (P–R) Section in situ hybridization using a probe of Xhmgb3 for Xenopus
embryos (S and T) or in the retina (U). Yellow arrows indicate the expression of
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that rax is able to efficiently act in the neural tissue (Casarosa et
al., 1997; Mathers et al., 1997). Recently, Xp53 was identified
as a posteriorizing factor that acts efficiently after neural
induction by noggin in animal caps (Takebayashi-Suzuki et al.,
2003). Similarly, we co-injected synthetic RNAs of rax (rax
RNA) and smad10 (smad10 RNA), which induces neural tissue
in Xenopus (LeSueur and Graff, 1999; LeSueur et al., 2002),
speculating that rax could induce downstream genes efficiently
with smad10 in animal caps. We then performed a differential
screen using a Xenopus macroarray. We prepared probes for
macroarray screening from animal caps that either had or had
not been injected with rax and smad10 RNAs. We speculated
that genes induced by rax would be mainly expressed in the
anterior neural plate and in the optic vesicle. We identified four
genes, which showed relatively similar expression patterns to
that of rax. Subsequently, we examined whether those genes are
induced in animal caps by rax alone using Northern
hybridization. We found that one gene, which encodes a high
mobility group b (hmgb) protein, was induced by rax alone in
animal caps (Fig. 1A). Next, we examined whether rax RNA,
together with β-galactosidase (β-gal) RNA (75 pg) as a tracer,
can induce Xhmgb3 expression in Xenopus embryos to exclude
that Xhmgb3 is downstream of smad10 alone. Xhmgb3
expression was enhanced upon rax injection in Xenopus
embryos (34%, n = 41) (Fig. 1B), while knock down of rax
by an antisense morpholino-oligo against rax (raxMO, 1 pmol)
reduced Xhmgb3 expression in Xenopus embryos (32%, n = 31)
(Fig. 1C). We then examined whether rax also regulates
Xhmgb3 expression in the brain because rax is expressed in the
prospective forebrain before neural tube formation. We found
rax MO (0.5 pmol) reduced Xhmgb3 expression on the injected
side (100%, n = 4) (Fig. 1D), suggesting that the action of rax in
the neural plate is required for normal expression of Xhmgb3.
Xenopus laevis is a functional diploid, but most of the genes
are present in two copies as a result of its allotetraploid origin
(Graf and Kobel, 1991). We found a Xenopus hmgb3, which has
high homology with the gene we identified (91% identical in
nucleic acid sequence), in the database (GenBank accession
number: BC044009). Therefore, we referred to the gene we
identified as Xhmgb3b and to the gene in the datebase as
Xhmgb3a in this manuscript. In this report, all mentions of
Xhmgb3 will refer to Xhmgb3b.
Developmental expression of Xhmgb3
Xhmgb3 is expressed in the entire animal sphere at stage 10.5
(Fig. 1F). At stage 12.5, Xhmgb3mRNA is expressed across the
whole neural plate, however, it is strongly expressed in the
anterior region (Fig. 1G). At stage 15, the Xhmgb3 expression
increased significantly in the anterior part of the neural plate
(Fig. 1H). At stages 18/19 (Fig. 1I), Xhmgb3 expression was
observed in the entire central nervous system and at stage 25,
strong signal was detected in the optic vesicle (Fig. 1J). At later
stages, Xhmgb3 expression was observed in the forebrain,
midbrain, hindbrain, otic vesicle, anterior part of the spinal cord,
branchial arches and eye (Figs. 1K–M). At stage 39, Xhmgb3expression decreased significantly and the hybridization signal
was barely observable (Fig. 1N). We did not detect a significant
Xhmgb3 signal at later stages by whole-mount in situ
hybridization (data not shown). Xhmgb3 was expressed
throughout prospective retina at stage 25 when most cells are
proliferating (Fig. 1O). Xhmgb3 expression was detected in the
forebrain at stage 41 by section in situ hybridization (Fig. 1P).
We examined Xhmgb3 expression further in the retina. At stages
40 and 41, Xhmgb3 was expressed in the ciliary marginal zone
(CMZ), where cell proliferation occurs throughout the animal's
life (Figs. 1Q and R). We also found that Xhmgb3a showed a
similar expression pattern to that of Xhmgb3 (Figs. 1S–U) and
that Xhmgb3a was regulated by rax (100%, n = 3) (Fig. 1E),
suggesting that Xhmgb3 and Xhmgb3a are redundant factors in
Xenopus.
Overexpression of Xhmgb3 enlarges the eye and brain
structures
To investigate the roles of Xhmgb3 during embryonic
development in Xenopus, we first performed overexpression
experiments. In the Xhmgb3-injected embryos, we observed an
enlargement of the eye and brain structure on the injected side
(Figs. 2B and C), while not in the β-gal-injected embryos
(Fig. 2A). Some embryos showed an expansion of retinal
tissue upon Xhmgb3 expression (Fig. 2D). We quantified the
effect of Xhmgb3 overexpression based on eye diameters
(Figs. 2E and F). In the embryos injected with β-gal and
Xhmgb3 RNAs, the distribution of eye sizes was significantly
biased toward enlarged eye classes, while that was not the case
in the control embryos (Fig. 2E). Around 50% of the embryos
injected with Xhmgb3 RNA showed an increase in the
diameter of the eye (Figs. 2E and F). This phenotype was
maximal in embryos injected with Xhmgb3 RNA between 225
pg and 300 pg at 4- or 8-cell stage. We did not observe any
morphological abnormality of embryos that were injected with
Xhmgb3 RNA into the ventral blastomere on the animal side
or vegetal side of embryos at 8-cell stage by visual inspection
(data not shown).
Overexpression of Xhmgb3 promotes progenitor cell
proliferation in the developing retina and brain
We next examined whether Xhmgb3 promotes cell prolifer-
ation using an anti-phospho-histone H3 antibody (αPH3Ab),
which detects mitotic cells. We analyzed the number of
αPH3Ab positive cells in each eye (213 sections from 13
embryos injected with β-gal RNA and 263 sections from 15
embryos injected with Xhmgb3 + β-gal RNAs). We also
analyzed the brain (forebrain-midbrain) (354 sections from 14
embryos injected with β-gal RNA and 337 sections from 14
embryos injected with Xhmgb3 + β-gal RNAs). The injected
side was determined by anti-β-gal immunostaining (Figs. 2G
and I). We observed an increase of the relative frequencies of
mitotic cells in the developing retina and brain in the Xhmgb3-
injected embryos (Figs. 2J–L), while not in the β-gal RNA-
injected embryos (Figs. 2H, K and L).
Fig. 2. Xhmgb3 increases eye and brain sizes due to promoted cell proliferation. (A–L) Analysis of embryos injected with synthetic RNAs at 4- or 8-cell stage into one
dorsal blastomere on the animal side. An embryo (stages 37/38) injected with β-gal RNA (A) and embryos (stages 37/38) injected with β-gal and Xhmgb3RNAs (B, D
and F). An embryo (stage 43) injected with Xhmgb3 RNA (C). Cryosection of the retina at stage 37/38 following X-gal staining (D). Dorsal views with anterior to the
top (A–C) and the injected side or area is indicated by β-gal activity in blue (A, B and D). Yellow arrows indicate enlarged eye (B, C and F) and hyperplasia of the
retinal tissue (D). Yellow brackets indicate the sizes of anterior brain of injected side and control side. (A–C). Asterisks indicate enlarged brain structures (B and C). (E
and F) Quantification of an eye enlargement in Xhmgb3-injected embryos based on diameters of the eye. Note that distribution of eye sizes of Xhmgb3-injected
embryos are significantly biased to the enlarged eye classes, while that is not the case in the embryos injected with β-gal RNA (E). Isolated eyes from Xhmgb3 and β-
gal RNAs-injected embryos (F). Data are means from three experiments with the numbers shown ± SEM (E). (G–J) Immunostaining of cryosections from embryos
injected with only β-gal RNA (G and H) or Xhmgb3 + β-gal RNAs (I and J) using an anti-phospho-histone H3 antibody (H and J) or anti-β-gal antibody (G and I). The
injected sides are represented by β-gal expression (G and I). (K, L) The average ratio of the mitotic cells in the eye or brain between the injected side and the un-
injected side (labeled “no” on the figure). Data are means ± SEM (retina: Xhmgb3-injected embryo, P = 0.0018 (Wilcoxon signed-rank test), control side: 2269 cells,
injected side: 2906 cells; β-gal-injected embryo, control side: 1687 cells, injected side: 1635 cells) (brain: Xhmgb3-injected embryo, P = 0.0019 (Wilcoxon signed-
rank test), control side: 1249 cells, injected side: 1226 cells; β-gal-injected embryo, control side: 1038 cells, injected side: 1272 cells) (K, L). (M, N) Clonal analysis of
control (GFP) and Xhmgb3-overexpressed retinas. Retinal section (stage 41) showing GFP positive cells (green) lipofected with GFP construct (M). Percentage of
retinal cell types observed in eyes lipofected with GFP/pCS2+ or GFP/Xhmgb3 (N). n = 506 cells from nine embryos for GFP, n = 1264 cells from eleven embryos for
Xhmgb3. Data are means ± SEM. *P = 0.045 (Mann–Whitney'sU test). le, lens; re, retina; rpe, retinal pigmented epithelium; ph, photoreceptor cell; bi, bipolar cell; ga,
ganglion cell; am, amacrine cell; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer.
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affects cell fate decisions of progenitor cells in the developing
retina (Figs. 2M and N). DNA was lipofected into the anterior
neural fold of stage 18 embryos. GFP DNA was colipofectedto mark the lipofected cells. Embryos were fixed at stage 41,
sectioned on a cryostat at a thickness of 10 μm. GFP-positive
cells were counted and the cell type identified based upon their
laminar position and morphology as previously described
Table 1
Summary of rescue experiments
N50% b50% Completely rescued
Xhmgb3 MO (n = 27) 74% 26% 0%
Xhmgb3 MO + Xhmgb3
RNA (450 pg) (n = 20)
55% 35% 10%
Xhmgb3 MO + Xhmgb3
RNA (750 pg) (n = 23)
9% 39% 52%
An injection of Xhmgb3 MO resulted in small eyes with 74% showing a more
than 50% decrease in size compared to the control eye diameter and 26%
showing a less than 50% decrease in size compared to the control (n = 27). An
injection of 450 pg of Xhmgb3 RNA at the 4-cell stage rescued the knock-down
phenotype with 55% showing an over 50% of reduction of the eye diameter
compared to the control side, 35% showing a less than 50% reduction of eye
diameter compared to the control, and 10% completely rescued in eye size
(n = 20). Furthermore, an injection of 750 pg of Xhmgb3 RNA at 4-cell stage
rescued the knock-down phenotype more efficiently with 9% showing an over
50% of reduction of the eye diameter compared to the eyes of the control side,
39% showing a less than 50% reduction of eye diameter compared to the control
side and 52%, completely rescued in eye size (n = 23).
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photoreceptor cells and Müller glia were affected in the
Xhmgb3-injected retina (Fig. 2N). It appeared, however, that
Xhmgb3 did not affect cell fate decisions significantly
compared with other factors previously reported (Dorsky et
al., 1997; Viczian et al., 2003). These results suggest that
Xhmgb3 is involved in photoreceptor production at the
expense of Müller glia production, although the increase in
the population of photoreceptor cells is not statistically
significant (P = 0.0742).
Xhmgb3 is required for eye and brain development in Xenopus
To examine whether Xhmgb3 is required for normal Xenopus
development, we performed knock down experiments using
Xhmgb3 MO. Xhmgb3 MO-injected embryos showed smaller
eye and brain structures (Figs. 3A–C and E), compared to the
control MO-injected embryos (Fig. 3D). An injection of
Xhmgb3 MO resulted in small eyes with 74% showing a more
than 50% decrease in size compared to the control eye diameter
and 26% showing a less than 50% decrease in size compared to
the control (n = 27, Table 1). We tested if co-injection of
Xhmgb3 RNA could rescue the phenotype resulted from
Xhmgb3 MO injection (Fig. 3F, Table 1). An injection of 450
pg of Xhmgb3 RNA at the 4-cell stage rescued the knock-down
phenotype with 55% showing an over 50% of reduction of the
eye diameter compared to the control side, 35% showing a less
than 50% reduction of eye diameter compared to the control,
and 10% completely rescued in eye size (n = 20). Furthermore,
an injection of 750 pg of Xhmgb3 RNA at 4-cell stage rescued
the knock-down phenotype more efficiently with 9% showing
an over 50% of reduction of the eye diameter compared to the
eyes of the control side, 39% showing a less than 50% reduction
of eye diameter compared to the control side and 52%,
completely rescued in eye size (n = 23). We did not observe
morphological abnormalities in embryos injected with Xhmgb3
MO into the ventral blastomere on either the animal side or the
vegetal side of the embryos (data not shown). These resultsFig. 3. Knocking down Xhmgb3 results in reduced eye and brain structure. (A–F) Em
each picture) at two-cell stage into one blastomere (A and B) or at 4- or 8-cell stage in
the top (A), dorsal views with anterior to the top (B, C). (D) Control MO, (F) Xhmgb
arrowhead indicates eye of un-injected side (A). Green arrows indicate reduced eyeindicate that Xhmgb3 is required for the normal eye and brain
development in vivo.
Rax is required for the initial expression of XOptx2
XOptx2, a Six-family transcription factor, promotes cell
proliferation in the eye field and in the developing retina in
Xenopus (Zuber et al., 1999). Since the expression of XOptx2
mRNA begins after rax expression (Zuber et al., 1999, 2003),
we investigated whether rax is required for the expression of
XOptx2 by using the dominant inhibitory mutant of rax (rax-
EnR), in which the engrailed repressor domain is fused to rax,
and rax MO (Andreazzoli et al., 1999, 2003). Injections of
rax-EnR RNA or rax MO significantly reduced XOptx2
expression (rax MO 0.5 pmol, 56% reduction, n = 16; rax
MO 1 pmol, 68% reduction, n = 19; rax-EnR, 70% reduction,
n = 34) (Figs. 4A, B, F and Table 2) and resulted in small
eyes (Fig. 4I). In contrast, they did not largely affect thebryos injected with Xhmgb3 MO and/or Xhmgb3 RNA (as indicated at the top of
to one dorsal blastomere on the animal side (C–F). Anterior view with dorsal to
3 MO and Xhmgb3 RNA. Yellow arrow indicates the cement gland and yellow
and brain structures. Lateral views with anterior to the left (D–F).
Fig. 4. Rax is required for the initial expression of XOptx2 mRNA in Xenopus. (A–I) Embryos were injected at 4- or 8-cell stage into one dorsal blastomere on the
animal side and injected side is indicated by β-gal activity in blue. Embryos (stages 17/18) injected with rax MO or rax-EnR RNAwith β-gal RNA (A–H). Expression
of XOptx2 (A, B and F), Pax6 (C, D and G) or Six3 (E, H). Anterior views with dorsal to the top (A–H). (I) Embryos (stages 37/38) injected with raxMO (0.5 pmol).
Dorsal views with anterior to the top (I). Yellow arrows indicate reduced eyes (I).
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rax MO 1 pmol, 13% reduction, n = 17; rax-EnR, 12%
reduction, n = 25) (Figs. 4C, D and G) or Six3 (rax MO 0.5
pmol, 0% reduction, n = 19; rax-EnR, 4% reduction, n = 24)
(Figs. 4E and H). These results indicate that rax is required
for XOptx2 expression in Xenopus.
Roles of Xhmgb3 in eye development
Inhibition of rax function reduces eye and brain sizes
mainly due to the reduced cell proliferation (Andreazzoli et
al., 2003; Casarosa et al., 2003). We examined whether or not
Xhmgb3, which we identify as a downstream target of rax,
rescues the knock-down phenotype by rax MO injection. Co-
injection of rax MO (1 pmol) and Xhmgb3 RNA, however,
still resulted in reduced eye and brain sizes (data not shown),
suggesting that other factor(s) functions downstream of rax.
We then tested whether co-expression of Xhmgb3 andTable 2
Summary of the effects of loss-of-function on the gene expressions
Optx2 (%) Pax6 (%) Six3 (%)
raxMO (0.5 pmol) 56 (n = 16) 0 (n = 16) 0 (n = 19)
raxMO (1 pmol) 68 (n = 19) 13 (n = 17) 0 (n = 15)
raxEnR 70 (n = 34) 12 (n = 25) 4 (n = 24)
Xenopus embryos were injected with raxMO or raxEn RNA at 4- to 8-cell stage
into one dorsal blastomere on animal side and harvested at stages 17/18. Whole
mount in situ hybridization was performed with DIG-labeled antisense RNA
probes for XOptx2, Pax6 or Six3. %: The percentage of embryos that showed
reduced expression of genes indicated. n: The number of embryos analyzed.XOptx2 rescues the small eye phenotype. We injected 5 pg
of XOptx2 RNA at 4-cell stage, since an injection of XOptx2
between 7.5 pg and 10 pg at 2-cell stage showed a maximal
effect (Zuber et al., 1999). However, XOptx2 and Xhmgb3
failed to rescue the phenotype caused by rax MO (1 pmol)
(data not shown), suggesting that other molecule(s) acts
downstream of rax and is required for normal development
(Andreazzoli et al., 2003; Kennedy et al., 2004). We then
reduced the amount of rax MO for injection (from 1 pmol to
0.5 pmol), leading to a partial inhibition of rax-activated
pathways. Embryos injected with rax MO (0.5 pmol) showed
small eyes (Fig. 4I). We assessed the effect of Xhmgb3 and
XOptx2 expression based on the eye diameters in the injected
side. Xhmgb3 did not rescue the knock-down effect by rax
MO (0.5 pmol) (data not shown). On the other hand, XOptx2
rescued the smaller eye phenotype caused by rax MO (0.5
pmol) (around 65% of embryos are completely rescued) (Fig.
5A). Co-injection of Xhmgb3 + XOptx2 RNAs showed
synergistic effect to rescue the knock-down phenotype by
rax MO (around 80% of embryos are completely rescued)
(Fig. 5A), suggesting that Xhmgb3 may act in a different
pathway from XOptx2. To test whether Xhmgb3 acts in an
independent pathway to XOptx2, we performed rescue
experiments by co-injection of Xhmgb3 MO and XOptx2
RNAs (Figs. 5B–I). Embryos injected with Xhmgb3
MO + XOptx2 RNAs showed enlarged eyes similar to those
of XOptx2 RNA only-injected embryos around at early
tailbud stages (Figs. 5C, E and J). However, these embryos
eventually resulted in small eyes at stages 37/38 (Figs. 5I and
L), while XOptx2 only-injected embryos resulted in large eyes
Fig. 5. Xhmgb3 acts in the rax-mediated pathway and is essential for eye development at later developmental stages. (A–L) Embryos were injected with MO and/or
synthetic RNA at 4-cell stage into one dorsal blastomere on the animal side. Injected side is indicated by β-gal activity in blue (G, I, K and L). Rescue experiment (A).
Data are means ± SEM (A). (B–I) Rescue experiments injected with Xhmgb3 MO and XOptx2 RNA. Xenopus embryos at stage 28 (B–E) or at stages 37/38 (F–I)
injected with XOptx2 RNA (B, C, F and G) or XOptx2 RNA and Xhmgb3MO (D, E, H and I). Lateral views with anterior to the right (B, D, F and H: control side) or
anterior to the left (C, E, G and I: injected side). Dorsal view of a embryo in E (J). Dorsal view of embryos in G (K) and I (L). Yellow arrows indicate enlarged optic
vesicles or enlarged eyes (C, E, G, J and K). Green arrows indicate reduced eyes (I and L). (M, N) Detection of apoptotic cells in Xenopus retina. White dotted lines
delineate the neural retina (M, N). Embryos were injected with XOptx2 RNA and Xhmgb3MO at 4-cell stage into one dorsal blastomere on animal side and harvested
at stages 31/32. Un-injected retina (M) and injected retina (N). (O) Northern blot analysis of total RNA from animal caps injected with water, rax or XOptx2. Xhmgb3
cDNA fragment was used as a labeled probe. Similar results were obtained in at least three independent experiments. The lower panel shows EtBr staining of ribosomal
RNA (O). (P) Expression of XOptx2 in Xenopus embryos (stages 17/18) injected with Xhmgb3 RNA at 4- or 8-cell stage into one dorsal blastomere on the animal side.
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occurs in the eye of the injected side. The eyes injected with
XOptx2 RNA and Xhmgb3 MO appear to stop growing
around stage 28 (data not shown). We detected few apoptotic
cells in the retina of the un-injected side, although apoptotic
cells were detected outside the retina (Fig. 5M). In contrast,
we detected apoptotic cells in the retina of the injected side,
although the number of apoptotic cells was not significant
(Fig. 5N). These results suggest that Xhmgb3 may have an
anti-apoptotic role other than regulation of cell proliferation.
Alternatively, the reduction of Xhmgb3 activity may result in
defective cell proliferation followed by cell death. In
summary, these results suggest that Xhmgb3 is required for
eye development not in the early developmental stages but in
the late developmental stages. We next examined whether
XOptx2 and Xhmgb3 stimulate each other's expression.
Overexpression of XOptx2 did not affect the expression of
Xhmgb3 in embryos (data not shown). We also examined that
issue using animal caps and did not observe an enhancement
of Xhmgb3 transcription upon XOptx2 overexpression (Fig.
5O). Similarly, Xhmgb3 overexpression did not affect the
expression of XOptx2 in Xenopus embryos (at stages 17/18,
no change: 90%, reduction: 10%, n = 20; at stage 20, noFig. 6. Functional activity of Xhmgb3 in the anterior neural plate. An embryo (stage
RNAs and/or Xhmgb3MO as indicated at the top of each panel (A–L). Expression of r
The injected side is indicated by β-gal activity in blue (B–L) or by a yellow arrowchange: 100%, n = 11) (Fig. 5P, data not shown) nor the
transcription of XOptx2 mRNA in animal caps (data not
shown). These results raise the possibility that Xhmgb3 and
XOptx2 act in at least a partially independent manner.
Roles of Xhmgb3 in the early neural plate
We examined whether Xhmgb3 is required for the early
eye development, including the eye field and the optic vesicle
formation. We assessed the eye field development by the
expression domain of rax, Pax6 and Six3. It was reported that
the expansion of rax-expressing domain caused by over-
expression of XOptx2 is not due to the stimulation of rax
transcription but rather due to enhanced cell proliferation
(Andreazzoli et al., 2003; Zuber et al., 1999) (Fig. 6A). An
inhibition of XOptx2 by XOptx2HD-VP16 RNA injection (27
pg), which encodes a dominant inhibitory mutant of XOptx2
(Zuber et al., 1999), reduced the eye field (rax, 72%
reduction, n = 18, Fig. 6B). In contrast, Xhmgb3 MO did
not affect the eye field (rax, 0% reduction, n = 13, Fig. 6C;
Pax6, 10% reduction, n = 11, Fig. 6D; Six3, 0% reduction,
n = 11, Fig. 6E). Overexpression of Xhmgb3 appeared to
expand the eye field slightly (rax, 64% slight expansion,13) (A), embryos (stages 17/18) (B–L). Embryos were injected with synthetic
ax (A, B, C, F, G and H), Pax6 (D), Six3 (E), XOptx2 (I and J) or XEn2 (K and L).
(A).
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stimulate the transcription of rax in animal caps (data not
shown). We next examined whether or not Xhmgb3 is re-Fig. 7. Xhmgb3 directly activates the transcription of Xenopus c-mycmRNA. (A) Nor
RNA. A cDNA fragment of Xenopus c-myc was used as a labeled probe. Similar re
shows EtBr staining of ribosomal RNA. (B–F) Expression of Xenopus c-myc (B–D
Xhmgb3 RNA and β-gal RNA (D, F) into one dorsal blastomere at 4- or 8-cell stage o
18 (E and F). The injected side is indicated by β-gal activity in blue (C–F). (G–K) C
Xenopus c-myc gene and designs of primers for PCR. (H–K) ChIP assay with primers
or for c-myc protein-coding region (K). Immunocomplex was obtained from the ext
assay was performed at least 4 times independently and showed same results. (L) Mo
different stages through distinct mechanisms, leading to normal development of thequired for the expansion of the eye field induced by XOptx2
overexpression. Expansion of rax expression was not affected
by Xhmgb3 MO injection (rax, 71% expansion, n = 32, Fig.thern blot analysis of total RNA from animal caps injected with water or Xhmgb3
sults were obtained in at least three independent experiments. The lower panel
) or N-myc (E and F) or Xhmgb3 MO and β-gal RNA (C, E) or Xhmgb3 MO,
n the animal side. Expression was examined at stages 13/14 (B–D) or stages 17/
hIP analysis of Xhmgb3 for the c-myc promoter region. (G) Promoter region of
for c-myc promoter region (H and I), for distal region with respect to promoter (J)
ract of animal caps expressing 6x myc tag (H) or 6x myc-Xhmgb3 (I–K). ChIP
del of rax function in CNS development. Each molecule regulated by rax acts at
eye and brain.
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reduction of the eye field by XOptx2HD-VP16 (rax, 84%
reduction, n = 19, Fig. 6H). We also examined whether
Xhmgb3 is required for the normal expression of XOptx2
since Xhmgb3 expression begins before XOptx2 expression.
Xhmgb3 MO appeared to affect the expression of XOptx2,
although slightly, (53% reduction, n = 30, Fig. 6I), suggesting
XOptx2 expression is controlled by multiple factors. This
effect was rescued by co-injection of Xhmgb3 RNA with
Xhmgb3 MO (9.5% reduction, n = 21, Fig. 6J).
Since Xhmgb3 is expressed across the neural plate, we
examined the roles of Xhmgb3 in regions other than the anterior
neural plate. We observed that Xhmgb3 MO reduced XEn2
expression (76% reduction, n = 17, Fig. 6K), while over-
expression of Xhmgb3 rescued this effect (35% reduction,
n = 20, Fig. 6L), suggesting that Xhmgb3 is required for XEn2
expression or that Xhmgb3 is involved in the specification of
the neural plate caudal to the eye field.
Xhmgb3 controls the transcription of Xenopus c-myc mRNA
HMGB proteins interact with transcription factors and
modulate the events of transcription (Agresti and Bianchi,
2003; Agresti et al., 2005; Bustin, 1999; Thomas and
Travers, 2001; Travers, 2003). We, therefore, investigated
whether Xhmgb3 affects the transcription of cell cycle
regulator genes because Xhmgb3 promotes cell proliferation.
We tested various cell cycle factors and found that c-myc
transcription was upregulated upon Xhmgb3 overexpression
in animal caps (Fig. 7A). c-myc is expressed in the anterior
region and edge of the neural plate in Xenopus embryo (Fig.
7B). We next examined whether Xhmgb3 is required for the
expression of c-myc in vivo. C-myc expression was
diminished in the Xhmgb3 MO-injected embryos (stages
13/14, 70% reduction, n = 43; stages 17/18, 27% reduction,
n = 26) (Fig. 7C, data not shown), while this effect was
rescued by co-injection of Xhmgb3 RNA (Fig. 7D) (15%
reduction, n = 19). We did not observe expansion of the c-
myc expression domain upon Xhmgb3 overexpression (data
not shown), suggesting that Xhmgb3 may affect the
efficiency of c-myc transcription. We also found that the
expression of N-myc was downregulated by Xhmgb3 MO
injection (stages 17/18, 56% reduction, n = 25) (Fig. 7E),
while this effect was rescued by co-injection of Xhmgb3
RNA (17% reduction, n = 17) (Fig. 7F). Furthermore, we
performed a chromatin immunoprecipitation (ChIP) assay to
test whether overexpressed Xhmgb3, which is fused to a 6x
myc epitope-tag, is recruited around the promoter region of
Xenopus c-myc gene (Fig. 7G; Girard-Reydet et al., 2004).
We observed that 6x myc-Xhmgb3 was recruited around the
promoter region of Xenopus c-myc gene (Fig. 7I), but we did
not observe the recruitment of the only 6x myc tag (Fig.
7H). In contrast, 6x myc-Xhmgb3 did not appear to be
recruited to the coding region of Xenopus c-myc gene (Fig.
7K) nor to the ~3 kb upstream region of c-myc (Fig. 7J).
These results show that Xhmgb3 activates c-myc transcrip-
tion through interacting with the c-myc promoter.Discussion
Rax in the CNS development
It has been reported that co-expression of eye field
transcription factors, including rax/Rx, Pax6, Otx2, XOptx2,
Six3, Tll and ET, results in ectopic eye formation in Xenopus
in high frequency (Zuber et al., 2003). Pax6 can induce eye-
like structure in Xenopus, although not efficiently, suggesting
that Pax6 has an ability to induce eye cell fate in the neural
plate in vertebrates (Chow et al., 1999). XOptx2 promotes cell
proliferation specific to the eye field and developing retina
(Zuber et al., 1999). Six3 can induce retinal tissue and also
promotes retinal cell proliferation (Bene et al., 2004; Loosli et
al., 1999; Gestri et al., 2005). On the other hand, rax/Rx knock
out mice show no optic vesicle, while Pax6 mutant mice
develop the optic vesicle (Mathers et al., 1997; Hill et al.,
1991). In the Xenopus animal cap assay system, rax induces
the transcription of mRNAs of Pax6 and XOptx2 (Zuber et al.,
2003), and overexpression of rax induces optic vesicle-derived
tissue, RPE, in Xenopus (Mathers et al., 1997). Thus, previous
studies revealed that eye field transcription factors play their
roles in a complex context. These factors transform the neural
plate into the eye field and promote cell proliferation to
expand the eye field, leading to the optic vesicle formation
and eye development either, by activating or repressing the
downstream targets, or by binding to the other factors to
modulate the activity of them.
We showed inhibition of rax results in a reduction of the
expression of XOptx2, whereas Pax6 and six3 were hardly
affected, indicating that rax is required for the initial expression
ofXOptx2 inXenopus. As forPax6 and six3, theymay not require
rax function for their initial expression. This observation is
consistent with the previous analysis of the Rx3 mutant of
zebrafish (Loosli et al., 2003). On the other hand, rax/Rx null
mutant mice does not expressPax6 nor six3 in the locationwhere
optic vesicles are formed in wild type mice (Zhang et al., 2000).
This discrepancy may be caused by the difference of transcrip-
tional network between species or may reflect the differences of
developmental stages when we examined gene expressions.
Previous reports showed that rax induces Xhairy2A and Zic2
in the anterior neural plate in Xenopus at early stages and
antagonizes neural differentiation, leading to cell proliferation in
the anterior neural plate, including the eye field and prospective
anterior brain (Andreazzoli et al., 2003). On the other hand, the
existence of other pathways controlled by rax has been
suggested (Andreazzoli et al., 2003; Kennedy et al., 2004). In
this study, we showed that Xhmgb3 is controlled by rax in
Xenopus. We showed that Xhmgb3 is induced by rax in both
Xenopus embryos and in animal caps. The expression domain of
Xhmgb3 is not confined to the expression domain of rax, as is the
expression domain of Xhairy2A (Andreazzoli et al., 2003), and
knocking down rax results in a reduction of Xhmgb3 expression,
although it is not completely lost. These observations suggest
that other factors may contribute to the expression of Xhmgb3 in
the neural plate. In addition, we found that rax is required for the
initial XOptx2 expression. These observations suggest that rax
410 K. Terada et al. / Developmental Biology 291 (2006) 398–412functions through at least three pathways, Xhairy2A and Zic2
pathway, Xhmgb3 pathway, and XOptx2 pathway.
How is it that rax requires at least three pathways, as
described above, for cell proliferation during embryonic
development in Xenopus? One possible explanation is that
each pathway is required for a different stage. A previous report
demonstrates that Xhairy2A and Zic2 inhibit neural differenti-
ation in the early neural plate, leading to cell proliferation
(Andreazzoli et al., 2003). XOptx2 promotes eye field expansion
strongly, leading to the optic vesicle formation, and XOptx2 also
promotes cell proliferation in the developing retina (Zuber et al.,
1999). The Xhmgb3 knock down did not affect eye field
development. On the other hand, inhibition of XOptx2 reduced
the eye field. Furthermore, overexpression of XOptx2 does not
rescue the effect of knocking down Xhmgb3 around stages 37/
38, although XOptx2 rescued at earlier tailbud stages, suggesting
that Xhmgb3 has essential roles at later developmental stages.
Another explanation is that raxmay control cell proliferation
in the eye field mainly byXOptx2 and in the anterior neural plate,
eye and brain mainly by Xhairy2A, Zic2 and Xhmgb3 mainly.
The expression of XOptx2 is restricted to the eye field and eye,
while Xhairy2A and Zic2 are expressed in the anterior neural
plate. Xhmgb3 is also expressed in the neural plate in early
development and subsequently throughout the entire CNS
(Andreazzoli et al., 2003; Zuber et al., 1999; Fig. 1). After
neural tube formation the expression of rax is restricted to the
optic vesicle (Mathers et al., 1997; Casarosa et al., 1997),
whereas Xhmgb3 is expressed in the entire central nervous
system. This suggests that the regulation of Xhmgb3 expression
is switched, while the expression of rax in early neural plate is
required for the normal expression ofXhmgb3 in the anterior part
of embryos (Fig. 1D). The observation that rax MO reduced
brain size as well as eye size supports the idea that rax affects the
gene expression required for the normal development in anterior
brain. However, the mechanisms that determine the different
expression domain of Xhariy2A, Zic2, XOptx2 and Xhmgb3 are
unknown, although they appeared to be regulated by rax.
Roles of Xhmgb3 in cell proliferation
Hmgb proteins are nuclear proteins characterized by
conserved HMG domain A and B, which interact with the
DNA through the minor groove. Hmgb1/2 bind to DNA in a
sequence non-specific manner and with low affinity to single-
stranded, liner duplex and supercoiled DNA but exhibit a higher
affinity for unusual DNA structures such as four-way junctions
and cisplatin-modified DNA. The structures of these proteins
show high homology, over 80% amino acid identity, and their
biochemical properties are so far indistinguishable. It, therefore,
has been suggested that recently identified hmgb3 also possesses
similar biochemical properties to those of hmgb1/2 (Agresti and
Bianchi, 2003; Bustin, 1999; Thomas andTravers, 2001; Travers,
2003; Vaccari et al., 1998). However, recent studies demonstra-
ted that biological functions of hmgb1 and hmgb2 are not
completely identical (Calogero et al., 1999; Ronfani et al., 2001).
The in vivo roles of hmgb3 during embryonic development
have not been clarified. Xhmgb3 mRNA is expressed mainly inthe central nervous system, including eye and brain, and its
expression in the retina is restricted to the CMZ, where cell
proliferation continues throughout the animal's life in amphi-
bians at stage 40. It has been reported that the CMZ expresses
factors for retinal progenitor proliferation and/or differentiation,
including rax/Rx, Six3, Pax6, Cyclin D1, X-Notch-1 and bHLHs
(Dorsky et al., 1997; Ohnuma et al., 2002; Perron et al., 1998).
We observed a very weak effect of Xhmgb3 on the cell fate
decisions of retinal progenitor cells, implying that Xhmgb3 may
have a minor function to regulate the potential of cell fates in
retinal progenitor cells. The reduction of Müller cells by
Xhmgb3 suggests that promoted cell proliferation by Xhmgb3 is
unlikely due to the inhibition of neurogenesis. Expression of
Xhmgb3 in the CMZ was observed in the peripheral region, in
which retinal progenitor cells are maintained (Ohnuma et al.,
2002; Perron et al., 1998), supporting our observation that
Xhmgb3 is necessary for cell proliferation in the retina of
Xenopus.
Myc has been reported to be involved in the promotion of
cell proliferation by controlling the expression of cyclin-
dependent kinase CDK4 (Hermeking et al., 2000), the
Cdc25A phosphatase that activates CDKs (Galaktionov et al.,
1996), cyclin D2 (Bouchard et al., 1999; Perez-Roger et al.,
1999) and E2F family (Leone et al., 2001). Myc may further
stimulate cyclin E/Cdk2 activity by directly or indirectly
abrogating the function of the CDK inhibitor p27Kip1 (O'Hagan
et al., 2000; Perez-Roger et al., 1999) and by inducing the Rb
antagonist Id2 (Lasorella et al., 2000). Myc also represses genes
that function to inhibit proliferation such as gadd45 (Marhin et
al., 1997), p15Ink4b (Staller et al., 2001), and p21Cip1 (Gartel et
al., 2001). The reduction of c-myc levels results in reduced body
mass owing to multiorgan hypoplasia in mice (Trumpp et al.,
2001) and c-myc knock out cells showed reduced cell
proliferation (de Alboran et al., 2001). The expression of c-
myc was detected by whole mount in situ hybridization only up
to tailbud stages (Bellmeyer et al., 2003), although Northern
blotting detected the expression even after tailbud stages in
Xenopus (Schreiber-Agus et al., 1993). This suggests that c-myc
is expressed widely in embryos at relatively low expression
level after tailbud stages in Xenopus. It has been shown that c-
myc knock down results in defects in cranial region, including
eye and brain in Xenopus (Bellmeyer et al., 2003). We found
that Xhmgb3 directly controls c-myc transcription, suggesting
Xhmgb3 contributes to cell proliferation by regulating c-myc
transcription. It has been reported that the hmgb1 mRNA level
is increased in tumors, including human breast carcinomas
(Brezniceanu et al., 2003). Hmgb1 has been reported to bind to
the estrogen receptor and to enhance gene expression in
cultured cells (Zhang et al., 1999). On the other hand, c-myc is
known as one of the targets of the estrogen receptor (Shang et
al., 2000). Those observations imply the possibility that
Xhmgb3 may be involved in the similar mechanisms of
transcription and tumorigenesis. Recently, it was reported that
the Notch signaling pathway activates the c-myc promoter in
hematopoietic stem cells (Satoh et al., 2004). In mice hmgb3 is
involved in cell proliferation and cell differentiation in
hemaopoietic cells (Nemeth et al., 2003, 2005). Possibly,
411K. Terada et al. / Developmental Biology 291 (2006) 398–412Xhmgb3 may have roles in modulating X-Notch-1 function via
c-myc regulation in progenitor cells in the CNS. Interestingly, it
was recently reported that c-myc is expressed in the CMZ of the
retina in zebrafish at late stages (Yamaguchi et al., 2005).
Together with our findings, we would like to propose the
model that rax functions by controlling various factors, including
Xhmgb3, XOptx2, Xhairy2 and Zic2, in CNS development and
that Xhmgb3 contributes to cell proliferation, at least in part, by
modulating the expression of c-myc gene (Fig. 7L).
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